The Earlier You Know

Much of the "War on Cancer" money goes to curing the disease but in the latest issue of Wired, Thomas Goetz writes about the Canary Foundation, which is focused on early detection.  There, researchers are working on developing biomarker blood tests -- using proteomics to pinpoint proteins -- and new imaging tools. "A good biomarker will tell us something we don't know.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.